欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
文章
报告
图书
公募
私募
资讯
搜 索
上传文档
首页
文章
报告
图书
公募
私募
资讯
金融终端
您的当前位置：
首页
>
研究报告
>
外盘报告
> 预览报告
Weaker-than-expected 1H17 results, but recovery expected. Maintain HOLD.
报告类型：港股公司研究
页数：4
文件大小：525K
上传时间：2024-09-20
机构：中国银河国际证券
作者：Harry He Wong Chi Man
54阅读
0收藏
0下载
下载PDF
所需积分：1
如何获取K积分
下载PDF
下载全文所需积分：1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
{{Creator}}
：
回复
{{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}}
[回复]
上传用户
文章
0
报告
0
图书
0
相关报告
NEED MORE CONCRETE ACTION TO UNLOCK VALUE
1H 2017 Results In Line With Expectations. Maintain BUY.
Lipusu looking gloomy. Execution in doubt. Downgrade to SELL.
Weak 1H17 Results Due to Unfavourable Market Conditions
1H 2017 Results Presentation Key Takeaways. Vietnam operation will have a positive impact.
Argentina credit: Aim higher
Indo coal - Indika 2Q17 result update and maintain Buy; D/G BUMA to Hold
Reiterate UW post-results. Ratings pressure remains
Chinese export prices and European plate continue to move up
Daily prices and news: High-grade iron ore rises as mills chase efficiency
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5763770","PageTitle":"Weaker-than-expected 1H17 results, but recovery expected. Maintain HOLD.-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":47,"Face":"/_files/face/0/6gxftef9.jpg","UName":"金蓄","UpArts":0,"UpRpts":23801,"UpLbies":17},"Rid":5763770,"IsPdf":false,"IsExist":false,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20170830-中国银河国际证券-三生制药-01530.HK-Weaker-than-expected1H17resultsbutrecoveryexpected.Ma","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}
微信公众号